Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181

NCT02044406 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1181181
DRUG: BI 1181181, R
DRUG: BI 1181181, T2
DRUG: Placebo to BI 1181181
DRUG: BI 1181181, T1

Sponsor

Boehringer Ingelheim